Skip to main content

iBio, Inc.

For the period ended Dec 31, 2025. Filed Feb 10, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2025 · Filed Feb 10, 2026

IBIO$0.80+7.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

PART I. FINANCIAL INFORMATION3
Item 1.Financial Statements:
​Condensed Consolidated Balance Sheets as of December 31, 2025 (unaudited) and June 30, 20253
​Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended December 31, 2025 and 20244
​Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended December 31, 2025 and 20245
​Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended December 31, 2025 and 20246
​Notes to the Condensed Consolidated Financial Statements7
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations36
Item 3.Quantitative and Qualitative Disclosures About Market Risk47
Item 4.Controls and Procedures47
PART II. OTHER INFORMATION48
Item 1.Legal Proceedings48
Item 1A.Risk Factors48
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds52
Item 3.Defaults Upon Senior Securities52
Item 4.Mine Safety Disclosures52
Item 5.Other Information52
Item 6.Exhibits53
SIGNATURES54
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.